Publications 2000
A listing of all Sanger Institute publications for 2000
We tackle some of the most difficult challenges in genomic research. This demands science at scale; a visionary and creative approach to research that pushes the boundaries of our understanding in ever new and exciting ways.
The Wellcome Sanger Institute is a world leader in genome research that delivers insights into human and pathogen biology that change science and medicine.
Sanger Institute’s history.
Join our community of world class thinkers and professionals at the Sanger Institute located in Cambridge. Together we achieve life-changing science.
We are committed to training the next generation of pioneering genome scientists and clinicians At the Wellome Sanger Institute, near Cambridge, we give students all the tools they need to succeed in the field of genomics research.
Women are represented in diminishing proportions as career levels progress and significant numbers of women leave science altogether. Scientists from marginalised groups such as LGBT+, BME and disabled scientists also do not achieve success at the same rates as their counterparts. With partners on the Wellcome Genome Campus we explore these issues, look to inspire researchers, develop discussion and drive change in current practices and policy.
The Director, Matthew Hurles, has overall responsibility for all areas of the Sanger Institute, reporting to GRL Board three times per year and the Wellcome Trust Board of Governors once per year.
The Sanger Institute’s mission is to use information from genome sequences to advance understanding of biology and improve health.
The Sanger Institute advises all levels of government both in the UK and across the world on the the role, impact and importance of genomic and life science research.
Sanger Institute’s Research Policies are designed to provide guidance to help researchers navigate the legislation relating to their research and to ensure that research is ethical and legal.
Wellcome Sanger Institute Branding Guidelines and Logos.
Management and support operations groups.
The Sanger Institute is sited on the Wellcome Genome Campus at the very heart of a global hub of fundamental and applied genomic research, education and engagement. The Campus is home to some of the world’s foremost institutes and organisations using genomes and biodata to deliver science with the reach, scale and imagination to solve some of humanity’s greatest challenges and maximise societal benefit
Our science is organised into six Scientific Programmes, each defining a major area of research with a particular biological, disease or analytic focus. In all cases, the studies provide insights into human, pathogen, cellular evolution, the phenotypic and hence biological consequences of genome variation and the processes which cause mutations.
Scientific and Faculty groups.
Wellcome Sanger Institute research programmes.
Collaborations with external partners.
Wellcome Sanger Institute tools directory.
Wellcome Sanger Institute data resources.
A list of research projects at the Wellcome Sanger Institute.
The Sanger Institute has published papers in some of the most prestigious scientific journals. We aim to publish research that will transform biology and improve healthcare.
Sanger Institute’s Research Policies are designed to provide guidance to help researchers navigate the legislation relating to their research and to ensure that research is ethical and legal.
The Sanger Institute’s contribution to research into COVID-19, including sequencing the SARS-CoV-2 virus.
Throughout the COVID-19 lockdown of 2020-2021 we hosted a series of monthly freely available and open virtual seminars, showcasing how our researchers are tackling some of the greatest challenges in human health and disease. From using genomic approaches to map all cell types in the human body, understand how cancer develops, and track the evolution and spread of global diseases, our senior scientists and faculty presented the latest developments in their field.
Almost 1,000 scientists, developers, engineers and skilled professionals work together to deliver the Sanger Institute’s cutting-edge genomic research.
The Sanger Leadership Team is an Executive Committee that reports to the Director and the Genome Research Limited (GRL) Board. It is designed to enable holistic and effective decision making, with transparency and accountability woven into its make up.
Our science is organised into five Scientific Programmes, each defining a major area of research with a particular biological, disease or analytic focus. In all cases, the studies provide insights into human, pathogen, cellular evolution, the phenotypic and hence biological consequences of genome variation and the processes which cause mutations.
Our science is organised into five Scientific Programmes, each defining a major area of research with a particular biological, disease or analytic focus. In all cases, the studies provide insights into human, pathogen, cellular evolution, the phenotypic and hence biological consequences of genome variation and the processes which cause mutations.
Our science is organised into five Scientific Programmes, each defining a major area of research with a particular biological, disease or analytic focus. In all cases, the studies provide insights into human, pathogen, cellular evolution, the phenotypic and hence biological consequences of genome variation and the processes which cause mutations.
The Wellcome Sanger Institute’s International Fellows Programme, designed to empower early-career researchers from LMICs with resources, mentorship, and funding to advance genomic research globally.
From PhD students and Postdoctoral Fellows, bioinformaticians and laboratory managers, these staff the support the delivery of pioneering science.
Non-science Staff.
Almost 1,000 scientists, developers, engineers and skilled professionals work together to deliver the Sanger Institute’s cutting-edge genomic research.
We deliver therapeutic, diagnostic and production benefits in areas as diverse as cancer, immunology, public health and personalised treatment.
We deliver therapeutic, diagnostic and production benefits in areas as diverse as cancer, immunology, public health and personalised treatment.
Our translation team was established in 2011 to help maximise the socioeconomic impact of the Sanger Institute’s discoveries. Members of this team specialise in helping to translate science into products and services and the Institute’s research has already produced marketed technologies that have been realised into benefits for patients in a variety of settings.
The Sanger Institute has always sought to facilitate improvements in human health. As the Institute continues to generate an ever deeper biological understanding of the genomic data and engender clinical perspectives to its science it will be faced with even greater opportunities to contribute to healthcare improvements.
We engage with the funding, R&D, service and clinical communities to promote real-world utilization of the Sanger Institute’s technologies and resources.
The Institute has a culture and history of scaling technologies, some of these capabilities have become spin-out companies that represent an important step towards the creation of a positive impact in today’s healthcare sector.
We create technologies and therapies of tomorrow through open dialogue with our many partners.
Wellcome Sanger Institute News.
A listing of all Sanger Institute publications for 2000